Heart rhythm watch: new study tracks ATTR patients on tafamidis
Knowledge-focused
Recruiting now
This study follows 200 adults with a heart condition called ATTR amyloidosis who are taking the drug tafamidis. Researchers will check for dangerous heart rhythm problems every six months using standard tests like electrocardiograms and Holter monitors. The goal is to better unde…
Sponsor: Paolo Milani • Aim: Knowledge-focused
Last updated May 15, 2026 11:56 UTC